C21H15BBrFN6O6 — CID 140927608
N-[2-[[4-[4-(3-bromo-4-fluorophenyl)-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]-1-hydroxy-2,1-benzoxaborinine-8-carboxamide (PubChem CID 140927608) has the molecular formula C21H15BBrFN6O6 and a molecular weight of 557.10 g/mol. Its IUPAC name is N-[2-[[4-[4-(3-bromo-4-fluorophenyl)-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]-1-hydroxy-2,1-benzoxaborinine-8-carboxamide.
| Compound Name | N-[2-[[4-[4-(3-bromo-4-fluorophenyl)-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]-1-hydroxy-2,1-benzoxaborinine-8-carboxamide |
|---|---|
| PubChem CID | 140927608 |
| Molecular Formula | C21H15BBrFN6O6 |
| Molecular Weight | 557.10 g/mol |
| Exact Mass | 556.03 |
| IUPAC Name | N-[2-[[4-[4-(3-bromo-4-fluorophenyl)-5-oxo-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]amino]ethyl]-1-hydroxy-2,1-benzoxaborinine-8-carboxamide |
| SMILES | O=C(NCCNc1nonc1-c1noc(=O)n1-c1ccc(F)c(Br)c1)c1cccc2c1B(O)OC=C2 |
| InChI | InChI=1S/C21H15BBrFN6O6/c23-14-10-12(4-5-15(14)24)30-19(29-35-21(30)32)17-18(28-36-27-17)25-7-8-26-20(31)13-3-1-2-11-6-9-34-22(33)16(11)13/h1-6,9-10,33H,7-8H2,(H,25,28)(H,26,31) |
| InChIKey | HNVHACOXOQLJBL-UHFFFAOYSA-N |
| XLogP | 1.31 |
| TPSA | 157.54 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 557.10 |
| LogP ≤ 5 | 1.31 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|